4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000187
Chief Executive Officer sold 12,498 shares at an average $449.67 ($5,620,006)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2021-06-17 | Sale | −6,732 | $449.35 | $3,025,024 | 160,172 | D: show line 1 in the form |
| Kummeth Charles R. Chief Executive Officer | 2021-06-17 | Sale | −1,698 | $450.39 | $764,762 | 158,474 | D: show line 2 in the form |
| Kummeth Charles R. Chief Executive Officer | 2021-06-17 | Sale | −1,050 | $451.54 | $474,117 | 157,424 | D: show line 3 in the form |
| Kummeth Charles R. Chief Executive Officer | 2021-06-17 | Sale | −109 | $452.13 | $49,282 | 157,315 | D: show line 4 in the form |
| Kummeth Charles R. Chief Executive Officer | 2021-06-18 | Sale | −2,583 | $449.09 | $1,159,999 | 154,732 | D: show line 5 in the form |
| Kummeth Charles R. Chief Executive Officer | 2021-06-18 | Sale | −326 | $450.37 | $146,821 | 154,406 | D: show line 6 in the form |
| Open-market sales · 12,498 sh · avg $449.67 · $5,620,006 | |||||||
Loading xslF345X03/edgar.xml…